Company lists · Data refreshed September 2026

Top 25 Oncology drug developers based in Australia

Name: Oncology drug developers based in Australia
Creator: RevenueBase
License: https://creativecommons.org/licenses/by/4.0/

Compiled by the RevenueBase Data Team Data refreshed Sep 20, 2026 46 companies tracked

RevenueBase identified 46 oncology drug developers headquartered in Australia as of September 2026 and tracks 2,205 professional contacts across them, including 370 with verified work emails. Sydney is the largest hub.

This list covers oncology drug developers headquartered in Australia, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, its RevenueBase Smart Search rating, and when it was last checked. Data refreshed September 20, 2026.

Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase Smart Search, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.

How to read this list HQ checked on every row RevenueBase Smart Search rating on every row Refreshed Sep 20, 2026 86% judged on-target in blind review

46Companies

2,205Contacts tracked

370Verified emails

Explore this list → Free signup · no credit card · 500 free credits

The 25 largest oncology drug developers based in Australia

Ranked by team size

Top 25 of 46 oncology drug developers based in Australia, ranked by team size, largest first. Data refreshed Sep 20, 2026. RevenueBase Smart Search rates how each company's information relates to oncology drug developers: strong evidence (its own description names it), partial (names part of it), indirect (matched on the rest of its profile rather than the description shown). Click a contact count to view that company's people.
#	Company	RevenueBase Smart Search	Headquarters	Employees	Contacts
1	Icon Group	Indirect evidence	Brisbane, AustraliaHQ checked Sep 20, 2026	1,001-5,000	1,443 contacts →
	Indirect evidence “Icon Group is a leading integrated healthcare provider with global reach across Australia, New Zealand, ASEAN, the United Kingdom and Germany.” Source: RevenueBase Database · checked Sep 20, 2026
2	Olivia Newton-John Cancer Research Institute	Indirect evidence	Heidelberg, AustraliaHQ checked Sep 20, 2026	201-500	166 contacts →
	Indirect evidence “The Olivia Newton-John Cancer Research Institute (ONJCRI)'s mission is to discover and develop breakthrough therapies and diagnostics that are more effective, tolerable and…” Source: RevenueBase Database · checked Sep 20, 2026
3	Vccc Alliance	Indirect evidence	Melbourne, AustraliaHQ checked Sep 20, 2026	11-50	92 contacts →
	Indirect evidence “The Victorian Comprehensive Cancer Centre Alliance is a powerful alliance of 10 leading research, academic and clinical institutions working together to accelerate and amplify…” Source: RevenueBase Database · checked Sep 20, 2026
4	Lumonus	Indirect evidence	Sydney, AustraliaHQ checked Sep 20, 2026	51-200	61 contacts →
	Indirect evidence “Hello.” Source: RevenueBase Database · checked Sep 20, 2026
5	OMICO	Indirect evidence	Kensington, AustraliaHQ checked Sep 20, 2026	51-200	51 contacts →
	Indirect evidence “Omico is an independent, national, not-for-profit organisation changing the way we fight cancer.” Source: RevenueBase Database · checked Sep 20, 2026
6	Engeneic	Indirect evidence	North Ryde, AustraliaHQ checked Sep 20, 2026	11-50	37 contacts →
	Indirect evidence “EngeneIC is a biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of chemotherapeutics and functional nucleic acids in…” Source: RevenueBase Database · checked Sep 20, 2026
7	Varian Asia Pacific, Japan & India	Indirect evidence	Singapore, AustraliaHQ checked Sep 20, 2026	51-200	29 contacts →
	Indirect evidence “At Varian, a Siemens Healthineers company, we envision a world without fear of cancer.” Source: RevenueBase Database · checked Sep 20, 2026
8	Oncosil Medical	Partial evidence	Sydney, AustraliaHQ checked Sep 20, 2026	11-50	27 contacts →
	Partial evidence “OncoSil Medical is a global medical device company focused on Interventional Oncology.” Source: RevenueBase Database · checked Sep 20, 2026
9	Tasman Health Care	Partial evidence	Southport, AustraliaHQ checked Sep 20, 2026	11-50	21 contacts →
	Partial evidence “Tasman Health Care is a comprehensive clinical Oncology research-focused group that is committed to delivering a high standard of individual quality patient care.” Source: RevenueBase Database · checked Sep 20, 2026
10	Kazia Therapeutics Limited	Partial evidence	Barangaroo, AustraliaHQ checked Sep 20, 2026	1-10	18 contacts →
	Partial evidence “Kazia Therapeutics Limited (NASDAQ: KZIA) is a clinical-stage oncology company focused on high-need cancers of the central nervous system and select aggressive solid tumors.” Source: RevenueBase Database · checked Sep 20, 2026
11	Immvirx	Indirect evidence	New Lambton Heights, AustraliaHQ checked Sep 20, 2026	11-50	18 contacts →
	Indirect evidence “ImmVirX is an Australian company founded in 2019 with a mission to improve outcomes for patients with cancer types in which immunotherapy treatments have limited effect.” Source: RevenueBase Database · checked Sep 20, 2026
12	Noxopharm Limited	Indirect evidence	Sydney - Castle Hill, AustraliaHQ checked Sep 20, 2026	11-50	13 contacts →
	Indirect evidence “Noxopharm Limited (ASX:NOX) is a clinical-stage Australian biotech company discovering and developing novel treatments for cancer and inflammation, including a pioneering…” Source: RevenueBase Database · checked Sep 20, 2026
13	Race Oncology	Partial evidence	Sydney, AustraliaHQ checked Sep 20, 2026	11-50	11 contacts →
	Partial evidence “Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care.” Source: RevenueBase Database · checked Sep 20, 2026
14	Cancer Research SA	Partial evidence	Adelaide, AustraliaHQ checked Sep 20, 2026	11-50	11 contacts →
	Partial evidence “We are a cancer research unit founded by Medical Oncologists based in Adelaide.” Source: RevenueBase Database · checked Sep 20, 2026
15	Prescient Therapeutics	Indirect evidence	Melbourne, AustraliaHQ checked Sep 20, 2026	11-50	10 contacts →
	Indirect evidence “Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.” Source: RevenueBase Database · checked Sep 20, 2026
16	Adalta LTD	Indirect evidence	Camberwell, AustraliaHQ checked Sep 20, 2026	1-10	10 contacts →
	Indirect evidence “AdAlta (ASX:1AD) aims to become a leader in cell therapy for cancer, providing a pathway for innovative cellular immunotherapies for solid cancers originating in Asia, and China…” Source: RevenueBase Database · checked Sep 20, 2026
17	Glytherix LTD	Indirect evidence	Macquarie Park, AustraliaHQ checked Sep 20, 2026	1-10	9 contacts →
	Indirect evidence “GlyTherix Ltd, is a targeted radiotherapy company with a clinical stage antibody product, Miltuximab®, showing an excellent safety profile in high unmet need cancers.” Source: RevenueBase Database · checked Sep 20, 2026
18	MLS BIO Molecular Life Science Biotech	Indirect evidence	Heidelberg, AustraliaHQ checked Sep 20, 2026	1-10	6 contacts →
	Indirect evidence “At MLS Bio, we are developing first-in-class small-molecule therapeutics targeting tetraspanins, a novel and underexplored class of cell-surface proteins that play a critical…” Source: RevenueBase Database · checked Sep 20, 2026
19	Canthera Discovery Canthera Discovery LTD	Indirect evidence	Melbourne, AustraliaHQ checked Sep 20, 2026	51-200	4 contacts →
	Indirect evidence “Canthera Discovery is dedicated to Finding Cures for Cancer.” Source: RevenueBase Database · checked Sep 20, 2026
20	Ascend Biopharmaceuticals LTD	Indirect evidence	South Melbourne, AustraliaHQ checked Sep 20, 2026	1-10	3 contacts →
	Indirect evidence “Ascend is a cancer immunotherapy company developing medicines to treat primary, recurrent and metastatic cancers.” Source: RevenueBase Database · checked Sep 20, 2026
21	Anthrocell PTY LTD	Partial evidence	Eveleigh, AustraliaHQ checked Sep 20, 2026	11-50	3 contacts →
	Partial evidence “Anthrocell Pty Ltd is a private Australian biotechnology company that has developed a novel technological platform for the development, production and manufacture of next…” Source: RevenueBase Database · checked Sep 20, 2026
22	TBG Diagnostics LTD	Indirect evidence	Brisbane, AustraliaHQ checked Sep 20, 2026	11-50	3 contacts →
	Indirect evidence “TBG Diagnostics Limited, formerly Progen Pharmaceuticals Limited, is a biotechnology company.” Source: RevenueBase Database · checked Sep 20, 2026
23	Biotranslation	Indirect evidence	Sidney, AustraliaHQ checked Sep 20, 2026	1-10	2 contacts →
	Indirect evidence “Redefining Cancer Therapies.” Source: RevenueBase Database · checked Sep 20, 2026
24	Aucentra Therapeutics	Indirect evidence	Adelaide, AustraliaHQ checked Sep 20, 2026	1-10	2 contacts →
	Indirect evidence “Aucentra discovers and develops oral small molecules for a range of cancers.” Source: RevenueBase Database · checked Sep 20, 2026
25	Oncology ONE PTY LTD	Partial evidence	Melbourne, AustraliaHQ checked Sep 20, 2026	1-10	2 contacts →
	Partial evidence “Oncology One is focused on building a diversified small molecule oncology pipeline and aims to help translate more of Australia’s world-class cancer research into treatments.” Source: RevenueBase Database · checked Sep 20, 2026

RevenueBase Smart Search

RevenueBase Smart Search assesses information from a company’s LinkedIn profile, information supplied directly by the company, its website, and other publicly available sources. It uses that information to rate how closely the company relates to this list’s category: oncology drug developers. Every row carries its rating and the description the rating was read from, so each one can be checked rather than taken on trust.

Strong evidence: The company's own public description of its business names oncology drug developers.
Partial evidence: Its own public description names part of oncology drug developers, so it works in or next to the category without describing itself that way.
Indirect evidence: The description shown does not name oncology drug developers. The match rests on the rest of the company's public profile rather than the one sentence quoted here, so this is the rating to check first.

RevenueBase Smart Search is how these lists are built: RevenueBase's data engine and AI assemble the companies that match a category defined in a user's own words, so a list can be about what companies actually do rather than about whichever industry code they were filed under.

Showing 25 of 46 oncology drug developers based in Australia

See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 370 reachable decision-makers.

Free signup · no credit card

View the full list →

Oncology drug developers based in Australia at a glance

As of Sep 20, 2026

16.8%Verified-email coverage

47.9Average contacts per company

11-50Median size (employees)

17.4%Largest-city concentration · Sydney

Sep 20, 2026Page data refreshed

Companies by employee count

1-10

11-50

51-200

201-500

1,001-5,000

Email recency for this list is measured worldwide rather than for Australia, so it is reported there. Company counts and contact totals on this page are exact for Australia, over 46 companies.

How this list was built

Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among oncology drug developers, so some rows will be adjacent to the category rather than pure plays. The description and RevenueBase Smart Search rating on every row are there so you can check each match yourself.

Source: The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase Smart Search, the natural-language company search available to every RevenueBase user.
What qualifies: Companies headquartered in Australia whose own description of what they do matches “oncology drug developers”. Matching reads each company's description, not its industry code or its name.
RevenueBase Smart Search: RevenueBase Smart Search is how this list is assembled and how each row is rated. RevenueBase's data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to a category defined in a user's own words. Each row is rated strong evidence (its own description names oncology drug developers), partial evidence (it names part of the category) or indirect evidence (the description shown names none of it and the match rests on the rest of the company's profile). The description supporting each rating is quoted on the row.
What we exclude: Companies whose own description does not clearly place them among oncology drug developers, and records with no verified work email. Companies headquartered outside Australia are excluded even when they keep an office there.
Match quality: In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and its RevenueBase Smart Search rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
Ranking: Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
Verification: Every listed company carries at least one verified work email, 370 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
Refresh: This page's figures were pulled from the company graph on September 20, 2026. Lists refresh periodically as the graph is re-checked.
Corrections: Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.

Frequently asked

What is RevenueBase Smart Search?

RevenueBase Smart Search is how RevenueBase decides which companies belong on this list and how strongly each one fits. Its data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to the category the list is about. Each row is rated strong evidence when the company's own description names oncology drug developers, partial evidence when it names part of the category, and indirect evidence when the description shown names none of it and the match rests on the rest of the company's profile.

How many oncology drug developers are there based in Australia?

RevenueBase identified 46 oncology drug developers headquartered in Australia as of September 2026, matched on each company's own description of what it does rather than its industry code.

What is the largest company on this list?

Icon Group, headquartered in Brisbane, tops this list with the largest team on record.

Which city has the most oncology drug developers?

Sydney leads with 8 headquartered companies, followed by Melbourne (6) and Adelaide (4).

How do I get contact information for these companies?

A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 370 verified decision-maker contacts tracked across these 46 companies.

How current is this list?

The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 20, 2026.

Ready to reach these companies? Verified emails and direct dials for all 46 oncology drug developers based in Australia. Start with a free account, no credit card.

Download this list →

Related lists

Oncology drug developers by geography

Browse the directory

About this data

RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase Smart Search, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.